Similar to other viruses, SARS-CoV-2 infection may induce a stress response that reduces insulin production, releases counterregulatory hormones, including cortisol and adrenaline, induces excessive gluconeogenesis and impairs glucose disposal, thereby causing transient hyperglycemia (84–86). Here, INS is linked to Hyperglycemia.